Ventilator-associated pneumonia: Gearing towards shorter-course therapy

Current Opinion in Infectious Diseases

Volumn 19, Issue 2, 2006, Pages 185-188

  De Jesus Chua, Thea ^a   File Jr , Thomas M ^a,b  

^a SUMMA HEALTH SYSTEM   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

Antimicrobial therapy; Duration of therapy; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CIPROFLOXACIN; GENTAMICIN; LINEZOLID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HIGH RISK PATIENT; HUMAN; INCIDENCE; MULTIDRUG RESISTANCE; OUTCOMES RESEARCH; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; SHORT COURSE THERAPY; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA; BACTERIAL PNEUMONIA; DRUG ADMINISTRATION; MICROBIOLOGY; VENTILATOR;

ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; HUMANS; PNEUMONIA, BACTERIAL; VENTILATORS, MECHANICAL;

EID: 33745008854     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qco.0000216630.59186.9e     Document Type: Review

References (17)

1. American Thoracic Society and the Infectious Disease Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and health-care associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416. An evidence-based comprehensive review of recommendations for management.
2. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 16:867-903.
3. Trouillet JL, Chastre J, Vaugnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531-539.
4. Rello J, Ausina V, Ricart M, et al. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med 1994; 20:193-198.
5. Yu VL, Singh N. Excessive antimicrobial usage causes measurable harm to patients with suspected ventilator-associated pneumonia. Intensive Care Med 2004; 30:735-738.
6. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. A consensus statement, American Thoracic Society. Am J Respir Crit Care Med 1996; 153:1711-1725.
7. Dennesen P, van der Ven A, Kessels A, et al. Resolution of clinical parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001; 163:1371-1375.
8. Rello J, Mariscal D, March F, et al. Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection. Am J Respir Crit Care Med 1998; 157:912-916.
9. Garrard CS, A'Court CD. The diagnosis of pneumonia in the critically ill. Chest 1995; 108:17S-25S.
10. Luna CM, Blanzaco D, Neiderman MS, et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003; 31:676-682.
11. Singh N, Rogers P, Atwood CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000; 162:505-511.
12. Ibrahim EH, Ward S, Sherman G, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29:1109-1115.
13. Micek ST, Ward S, Fraser VJ, et al. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator associated pneumonia. Chest 2004; 125:1791-1799. A paper suggesting that an antibiotic discontinuation policy designed for each institution could reduce unnecessary antimicrobial therapy for VAP.
14. Sandumienge A, Diaz E, Bodi M, Rello J. Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy". Intensive Care Med 2003; 29:876-883.
15. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs. 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290:2588-2598.
16. Combes A, Figliolini C, Trouillet JL, et al. Factors predicting ventilator-associated pneumonia recurrence. Crit Care Med 2003; 31:1102-1107.
17. Vidaur L, Gualis B, Rodriguez A, et al. Clinical resolution in patients with suspicion of ventilator-associated pneumonia: a cohort study comparing patients with and without acute respiratory distress syndrome. Crit Care Med 2005; 33:1248-1253.